Envestnet Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-19,149
| Closed | -$220K | – | 4192 |
|
|
2023
Q3 | $220K | Sell |
19,149
-6,353
| -25% | -$72.9K | ﹤0.01% | 3700 |
|
|
2023
Q2 | $645K | Buy |
25,502
+6,129
| +32% | +$155K | ﹤0.01% | 3064 |
|
|
2023
Q1 | $624K | Sell |
19,373
-9,446
| -33% | -$304K | ﹤0.01% | 3002 |
|
|
2022
Q4 | $532K | Buy |
28,819
+14,509
| +101% | +$268K | ﹤0.01% | 3064 |
|
|
2022
Q3 | $386K | Buy |
14,310
+3,642
| +34% | +$98.2K | ﹤0.01% | 3197 |
|
|
2022
Q2 | $147K | Sell |
10,668
-1,875
| -15% | -$25.8K | ﹤0.01% | 3700 |
|
|
2022
Q1 | $245K | Sell |
12,543
-7,751
| -38% | -$151K | ﹤0.01% | 3564 |
|
|
2021
Q4 | $331K | Sell |
20,294
-15,197
| -43% | -$248K | ﹤0.01% | 3352 |
|
|
2021
Q3 | $989K | Buy |
35,491
+558
| +2% | +$15.5K | ﹤0.01% | 2553 |
|
|
2021
Q2 | $1.04M | Buy |
34,933
+22,853
| +189% | +$677K | ﹤0.01% | 2502 |
|
|
2021
Q1 | $338K | Buy |
12,080
+2,497
| +26% | +$69.9K | ﹤0.01% | 3074 |
|
|
2020
Q4 | $272K | Sell |
9,583
-1,230
| -11% | -$34.9K | ﹤0.01% | 2972 |
|
|
2020
Q3 | $272K | Buy |
10,813
+357
| +3% | +$8.98K | ﹤0.01% | 2778 |
|
|
2020
Q2 | $255K | Sell |
10,456
-372
| -3% | -$9.07K | ﹤0.01% | 2762 |
|
|
2020
Q1 | $160K | Sell |
10,828
-1,434
| -12% | -$21.2K | ﹤0.01% | 2773 |
|
|
2019
Q4 | $199K | Buy |
+12,262
| New | +$199K | ﹤0.01% | 2924 |
|
|
2017
Q3 | – | Sell |
-27
| Closed | -$1K | – | 3064 |
|
|
2017
Q2 | $1K | Hold |
27
| – | – | ﹤0.01% | 3012 |
|
|
2017
Q1 | $1K | Hold |
27
| – | – | ﹤0.01% | 3076 |
|
|
2016
Q4 | $1K | Buy |
+27
| New | +$1K | ﹤0.01% | 3058 |
|